IsoPlexis is a life science technology company that accelerates the development of curative medicines and precision therapeutics. Their award-winning single-cell proteomics systems reveal unique biological activity in small subsets of cells, allowing researchers to connect more directly to in vivo biology and develop more precise therapies. Their integrated systems were named top innovation or design by The Scientist, Fierce, BIG Innovation, Red Dot, and multiple other companies. These systems are used globally to advance the field of single-cell biology as their customers overcome the challenges of complex diseases. Their products have been adopted by researchers around the world, including the top 15 global pharmaceutical companies and 45% of comprehensive cancer centers. Visit http://www.isoplexis.com to learn more.